Diphenhydramine vs Pembrolizumab

Diphenhydramine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Diphenhydramine and Pembrolizumab.

Mechanism of Action

Diphenhydramine: First-generation H1 antihistamine with anticholinergic properties.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Diphenhydramine — 2-8 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Diphenhydramine — C17H21NO.

Molecular Weight: Diphenhydramine — 255.3550 g/mol.

Type: Diphenhydramine — Small molecule; Pembrolizumab — Antibody.